Shizuo Nakamura

Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptide

Shizuo Nakamura, Norihito Murayama, Takafumi Noshita et al. · Brain Research · 2001 · 137 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Progressive Brain Dysfunction +10

Synthesis and Hypolipidemic Activities of Novel 2-[4-[(Diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3<i>H</i>)-Quinazolinones

Yasuhisa Kurogi, Yasuhide Inoue, Kazuhiko Tsutsumi et al. · Journal of Medicinal Chemistry · 1996 · 117 citations

Lipid Preparation, Pharmaceutical Science, Biochemistry +9

Masked Hypertension and Target Organ Damage in Treated Hypertensive Patients

M Tomiyama, T. Horio, Masayoshi Yoshii et al. · American Journal of Hypertension · 2006 · 108 citations · Full text

Efficient removal of protecting groups by a 'push-pull' mechanism. II. Deprotection of O-benzyltyrosine with a thioanisole-trifluoroacetic acid system without O-to-C rearrangements.

Yoshiaki Kiso, Kazuko Ukawa, Shizuo Nakamura et al. · Chemical and Pharmaceutical Bulletin · 1980 · 64 citations · Full text

Bioorganic Chemistry, Push-pull Mechanism, Organic Chemistry +16

Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease

Yuzo NAKAGAWA, Shizuo Nakamura, Yoshitoshi Kasé et al. · Brain Research · 1987 · 62 citations

Rat Hippocampus, Several Markers, Alzheimer's Disease +12